Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 93

Similar articles for PubMed (Select 23459401)

1.

Advances with RNA interference in Alzheimer's disease research.

Chen S, Ge X, Chen Y, Lv N, Liu Z, Yuan W.

Drug Des Devel Ther. 2013;7:117-25. doi: 10.2147/DDDT.S40229. Epub 2013 Feb 22. Review.

2.

RNA interference as a tool for Alzheimer's disease therapy.

Orlacchio A, Bernardi G, Orlacchio A, Martino S.

Mini Rev Med Chem. 2007 Nov;7(11):1166-76. Review.

PMID:
18045220
3.

Targeting Alzheimer's disease genes with RNA interference: an efficient strategy for silencing mutant alleles.

Miller VM, Gouvion CM, Davidson BL, Paulson HL.

Nucleic Acids Res. 2004 Jan 30;32(2):661-8. Print 2004.

4.

[From physiopathology to treatment of Alzheimer's disease].

Delacourte A.

Rev Neurol (Paris). 2006 Oct;162(10):909-12. Review. French.

PMID:
17028557
6.

Pharmacogenomics in Alzheimer's disease.

Cacabelos R.

Methods Mol Biol. 2008;448:213-357. doi: 10.1007/978-1-59745-205-2_10. Review.

PMID:
18370236
7.
8.

The therapeutic potential of siRNA in gene therapy of neurodegenerative disorders.

Koutsilieri E, Rethwilm A, Scheller C.

J Neural Transm Suppl. 2007;(72):43-9. Review.

PMID:
17982877
9.
10.

Alzheimer's disease pathogenesis and therapeutic interventions.

Parihar MS, Hemnani T.

J Clin Neurosci. 2004 Jun;11(5):456-67. Review.

PMID:
15177383
11.

Alzheimer's disease: recent advances and future perspectives.

Ubhi K, Masliah E.

J Alzheimers Dis. 2013;33 Suppl 1:S185-94. doi: 10.3233/JAD-2012-129028. Review.

PMID:
22810100
12.

[Alzheimer's disease: new prospects in therapy and applied experimental models].

Kubis AM, Janusz M.

Postepy Hig Med Dosw (Online). 2008 Aug 5;62:372-92. Review. Polish.

13.

Silencing of CDK5 as potential therapy for Alzheimer's disease.

López-Tobón A, Castro-Álvarez JF, Piedrahita D, Boudreau RL, Gallego-Gómez JC, Cardona-Gómez GP.

Rev Neurosci. 2011;22(2):143-52. doi: 10.1515/RNS.2011.015. Review.

PMID:
21476938
14.

Down-regulation amyloid beta-protein 42 production by interfering with transcript of presenilin 1 gene with siRNA.

Luo HM, Deng H, Xiao F, Gao Q, Weng W, Zhang PF, Li XG.

Acta Pharmacol Sin. 2004 Dec;25(12):1613-8.

15.

RNAi: a potential new class of therapeutic for human genetic disease.

Seyhan AA.

Hum Genet. 2011 Nov;130(5):583-605. doi: 10.1007/s00439-011-0995-8. Epub 2011 May 3. Review.

PMID:
21537948
16.

RNAi silencing in mouse models of neurodegenerative diseases.

Farah MH.

Curr Drug Deliv. 2007 Apr;4(2):161-7. Review.

PMID:
17456035
17.

Redox regulation of heat shock protein expression in aging and neurodegenerative disorders associated with oxidative stress: a nutritional approach.

Calabrese V, Scapagnini G, Colombrita C, Ravagna A, Pennisi G, Giuffrida Stella AM, Galli F, Butterfield DA.

Amino Acids. 2003 Dec;25(3-4):437-44. Epub 2003 Nov 7. Review.

PMID:
14661103
18.

Therapeutic RNA interference for neurodegenerative diseases: From promise to progress.

Gonzalez-Alegre P.

Pharmacol Ther. 2007 Apr;114(1):34-55. Epub 2007 Jan 25. Review.

PMID:
17316816
19.

A critical analysis of new molecular targets and strategies for drug developments in Alzheimer's disease.

Lahiri DK, Farlow MR, Sambamurti K, Greig NH, Giacobini E, Schneider LS.

Curr Drug Targets. 2003 Feb;4(2):97-112. Review.

PMID:
12558063
20.

Targeted introduction of V642I mutation in amyloid precursor protein gene causes functional abnormality resembling early stage of Alzheimer's disease in aged mice.

Kawasumi M, Chiba T, Yamada M, Miyamae-Kaneko M, Matsuoka M, Nakahara J, Tomita T, Iwatsubo T, Kato S, Aiso S, Nishimoto I, Kouyama K.

Eur J Neurosci. 2004 May;19(10):2826-38.

PMID:
15147316
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk